(Q103812885)

[17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hexadecanoate

1 reference

5alpha-ergosta-7,22-dien-3beta-ol

1 reference

(2R,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

5alpha-Ergosta-7,22-diene-2beta,3alpha,9-triol

1 reference

[(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hexadecanoate

1 reference

(24R)-5alpha,8alpha-Peroxy-24-methyl-28,29,30-trinor-5alpha-lanostane-9(11),22-diene-3beta-ol

1 reference

[(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,12Z,16Z)-octadeca-9,12,16-trienoate

ergosterol endoperoxide

1 reference

1 reference

1 reference

(2S,3S,5S,9S,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-2-methoxy-10,13-dimethyl-1,2,3,4,5,6,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,9-diol

1 reference

Lin Chun-Nan

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

Kuo Shih-Hsieh

series ordinal

2

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

Won Shen-Jeu

series ordinal

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

publication date

January 1993

1 reference

16 September 2022

3

1 reference

based on heuristic

inferred from page(s)

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

volume

32

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

issue

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

3 December 2020

page(s)

1549-1551

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/0031-9422(93)85177-S

Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST.

3 December 2020

cites work

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.19820650221

New terpenoids from Ganoderma lucidum and their bitterness.

9 March 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.49.1547

Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.34.2282

Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.2624

The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.1367

Identifiers

1 reference